Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Raasveld

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Immunology|February 1, 1995
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitroK J Parlevliet, M E Chamuleau, S L Yong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Low-dose OKT3 induction therapy following renal transplantation: a controlled studyK J Parlevliet, R J ten Berge, M H Raasveld, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Guidelines for the optimal use of muromonab CD3 in transplantationI J ten Berge, K J Parlevliet, M H Raasveld, et al.
Journal of Internal Medicine|June 1, 1991
Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alphaR de Wit, M H Raasveld, R J ten Berge, et al.
Kidney International|May 1, 1993
Complement activation during OKT3 treatment: a possible explanation for respiratory side effectsM H Raasveld, F J Bemelman, P T Schellekens, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Immunology|February 1, 1995
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitroK J Parlevliet, M E Chamuleau, S L Yong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Low-dose OKT3 induction therapy following renal transplantation: a controlled studyK J Parlevliet, R J ten Berge, M H Raasveld, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Guidelines for the optimal use of muromonab CD3 in transplantationI J ten Berge, K J Parlevliet, M H Raasveld, et al.
Journal of Internal Medicine|June 1, 1991
Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alphaR de Wit, M H Raasveld, R J ten Berge, et al.
Kidney International|May 1, 1993
Complement activation during OKT3 treatment: a possible explanation for respiratory side effectsM H Raasveld, F J Bemelman, P T Schellekens, et al.
Pageof 2